{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:55:35Z","timestamp":1790078135074,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.yebeh.2019.06.031","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T06:18:09Z","timestamp":1562653089000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"PA","title":["Why do some women with epilepsy use valproic acid despite current guidelines? A single-center cohort study"],"prefix":"10.1016","volume":"98","author":[{"given":"Magdalena","family":"Bosak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"S\u0142owik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Turaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2019.06.031_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.04.022","article-title":"Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts","volume":"81","author":"Meador","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0010","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","article-title":"Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry","volume":"17","author":"Tomson","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/ane.12965","article-title":"Antiepileptic drug polytherapy in pregnant women with epilepsy","volume":"138","author":"Vajda","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/ane.13005","article-title":"Valproate-associated foetal malformations \u2014 rates of occurrence, risks in attempted avoidance","volume":"139","author":"Vajda","year":"2019","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0025","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6\u202fyears (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0030","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s11064-017-2262-4","article-title":"Neurodevelopmental effects of antiepileptic drugs","volume":"42","author":"Kellogg","year":"2017","journal-title":"Neurochem Res"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0035","author":"European Medicines Agency"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.seizure.2016.01.019","article-title":"Prescribing trends for sodium valproate in Ireland","volume":"36","author":"Murphy","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/epi4.12228","article-title":"Valproic acid utilization among girls and women in Stockholm: impact of regulatory restrictions","volume":"13","author":"Karlsson Lind","year":"2018","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0050","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/ene.13610","article-title":"Declining trend in valproate use in Finland among females of childbearing age in 2012\u20132016 \u2014 a nationwide registry-based outpatient study","volume":"25","author":"Virta","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0055","author":"European Medicines Agency"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0060","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0065","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0070","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/epi.13021","article-title":"Valproate in the treatment of epilepsy in girls and women of childbearing potential","volume":"56","author":"Tomson","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0075","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1136\/jnnp-2017-317368","article-title":"Changing antiepilepsy drug-prescribing trends in women with epilepsy in the UK and Ireland and the impact on major congenital malformations","volume":"89","author":"Kinney","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yebeh.2018.04.009","article-title":"Changes in antiepileptic drug-prescribing patterns in pregnant women with epilepsy","volume":"84","author":"Meador","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0085","author":"Otwarte dane"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0090","first-page":"126","article-title":"Plany prokreacyjne i stosowanie antykoncepcji przez Polak\u00f3w w wieku reprodukcyjnym","volume":"15","author":"Izdebski","year":"2017","journal-title":"Zdr Publ Zarz"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0095","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.yebeh.2015.08.004","article-title":"Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy","volume":"52","author":"Bhakta","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0100","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1111\/epi.13320","article-title":"Contraceptive practices of women with epilepsy: findings of the epilepsy birth control registry","volume":"57","author":"Herzog","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yebeh.2017.11.013","article-title":"Pregnancy-related knowledge of women with epilepsy \u2014 an internet-based survey in German-speaking countries","volume":"79","author":"Dierking","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0110","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.yebeh.2013.09.044","article-title":"Pregnancy-related knowledge and information needs of women with epilepsy: a systematic review","volume":"31","author":"McGrath","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.06.031_bb0115","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12884-018-1842-x","article-title":"Sodium valproate and pregnancy: what are the risks and should we use a shared decision-based approach?","volume":"18","author":"Macfarlane","year":"2018","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019304135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019304135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:28:19Z","timestamp":1761503299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505019304135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":23,"alternative-id":["S1525505019304135"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.06.031","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Why do some women with epilepsy use valproic acid despite current guidelines? A single-center cohort study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}